Prev Arrow Stocks

Medtronic plc. ($MDT) Stock Forecast: Down 3.2% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Medtronic plc.?

Medtronic (MDT) is a multinational medical technology company headquartered in Ireland. It manufactures and sells medical devices for the treatment of various health conditions.

Why is Medtronic plc. going down?

MDT stock is down 3.2% on Oct 23, 2025 14:35

  • Medtronic (MDT) experienced a bearish movement today.
  • The market might have reacted negatively due to potential concerns about the company's financial performance or future growth prospects.
  • The news about businesses using Giftbit for rewards may not have directly impacted Medtronic's stock price, leading investors to focus on other factors affecting the company.
  • Investors may be reevaluating their positions in Medtronic based on broader market trends or specific industry developments.

MDT Price Chart

MDT Technical Analysis

MDT News

Rewards Are Working for Businesses Using Giftbit

CALGARY, Alberta, Oct. 21, 2025 ( GLOBE NEWSWIRE ) -- A growing number of companies are using Giftbit, a simple but powerful digital rewards platform, to achieve remarkable results. Gift cards and prepaid cards, sent instantly and at scale, are effective in countless business scenarios.

https://www.benzinga.com/pressreleases/25/10/g48331841/rewards-are-working-for-businesses-using-giftbit

0 News Article Image Rewards Are Working for Businesses Using Giftbit

Medtronic plc. Price History

04.03.2025 - MDT Stock was down 5.5%

  • MDT's stock (MDT) saw a -1.09% decrease, signifying a bearish trend.
  • The decline in MDT's stock price may be linked to investors taking profits following a recent uptick.
  • Concerns over potential regulatory changes in the healthcare sector could be making investors cautious, resulting in the drop in MDT's stock.
  • This bearish movement in MDT's stock is likely a brief correction in response to market conditions rather than an indication of the company's underlying performance.

14.00.2025 - MDT Stock was up 5.2%

  • Medtronic experienced a bullish movement, potentially influenced by positive analyst coverage and forecasts for Anteris Technologies, a player in the transcatheter valve replacement market.
  • Analysts' positive outlook on Anteris Technologies' DurAVR valve system, expected to gain a significant market share by 2030, likely bolstered investor confidence in the broader medical technology sector.
  • The encouragement of innovative technologies in healthcare may have positively impacted Medtronic, leading to an increase in its stock price.
  • The optimistic view on advancements in transcatheter valve replacement technologies could be a contributing factor to Medtronic's overall bullish stock performance.

20.07.2025 - MDT Stock was up 5.3%

  • Medtronic is a multinational medical technology company headquartered in Ireland, known for developing and manufacturing medical devices and equipment.
  • The company reported strong Q1 earnings and revenue beats, along with an increased full-year EPS outlook, despite a slight decline in stock price.
  • Q1 sales, adjusted EPS, and FY26 sales guidance all surpassed estimates.
  • Analysts revised their forecasts ahead of the earnings call, expecting positive results for the company.
  • The stock's positive movement today reflects the impact of the encouraging earnings report and raised sales guidance, even amid a minor drop in stock price.

23.09.2025 - MDT Stock was down 3.2%

  • Medtronic (MDT) experienced a bearish movement today.
  • The market might have reacted negatively due to potential concerns about the company's financial performance or future growth prospects.
  • The news about businesses using Giftbit for rewards may not have directly impacted Medtronic's stock price, leading investors to focus on other factors affecting the company.
  • Investors may be reevaluating their positions in Medtronic based on broader market trends or specific industry developments.

20.01.2024 - MDT Stock was up 2.7%

  • Medtronic reported a 5% increase in revenue for Q3 2024, showcasing strong performance in its core business segments.
  • The decision to exit unprofitable ventilator product lines and focus on high-demand areas like diabetes and cardiac rhythm management has boosted investor confidence.
  • The company's adjusted earnings exceeding consensus estimates and raising full-year outlook has further contributed to the bullish market movement.
  • The positive earnings and revenue surprises have likely driven investor optimism and propelled the stock price higher.

21.10.2023 - MDT Stock was up 2.0%

  • Medtronic reported strong financial results for its second quarter of fiscal year 2024, with worldwide revenue increasing by 5.3% as reported and 5.0% on an organic basis.
  • The company raised its full-year outlook after doubling its profit and experiencing revenue growth in Q2.
  • The diabetes segment outperformed expectations, contributing to the positive financial results and prompting Medtronic to raise its outlook.
  • Overall, the bullish market movement of Medtronic's stock can be attributed to the company's strong financial performance and positive outlook, particularly driven by the success of its diabetes segment.

11.09.2023 - MDT Stock was down 1.8%

  • Today, Medtronic (MDT) experienced a strong bearish movement in the stock market. This could be attributed to the following factors:
  • 1. Sustainability Report: The articles mention Medtronic's latest Sustainability Report, which highlights the company's efforts to make progress on environmental, social, and governance (ESG) issues. While sustainability initiatives are generally positive, the market may have reacted negatively to specific challenges or concerns outlined in the report.
  • 2. Market Performance: The article states that Medtronic's stock sank while the overall market was gaining. This suggests that there may be specific factors affecting Medtronic's performance, such as disappointing financial results, regulatory issues, or negative market sentiment towards the healthcare sector.
  • 3. Share Holdings: an article from EIN News Finance mentions that SevenBridge Financial Group LLC raised its holdings in Medtronic. While increased holdings can be seen as a positive indicator, it is possible that the market interpreted this as a sign of potential selling pressure or lack of confidence in the company's future prospects.
  • 4. Overall Market Conditions: It is important to consider the broader market conditions and trends when assessing the movement of a specific stock. Factors such as economic indicators, geopolitical events, or industry-specific news can influence investor sentiment and impact the performance of individual stocks like Medtronic.

21.04.2025 - MDT Stock was down 2.5%

  • The stock declined despite surpassing Q4 forecasts and revealing plans to spin off its Diabetes business.
  • The market's reaction could be attributed to profit-taking following recent positive developments, leading to a temporary downward trend.
  • Investors may be exercising caution concerning the potential implications of the spinoff on Medtronic's operational efficiency and future growth opportunities.
  • The stock's drop might also be influenced by broader market conditions or sector-specific factors impacting investor sentiment towards healthcare companies.

17.06.2024 - MDT Stock was up 3.6%

  • Forecasts suggest a promising future for the Medical Technology Platform Market, with frontrunners like Medtronic driving innovation. This optimistic projection likely influenced the bullish trend in MDT stock.
  • Medtronic's outperformance in market returns reflects investors' trust in the company's capabilities and growth prospects, boosting its stock value.
  • The award bestowed upon Medtronic for its commitment to disability inclusion underscores its dedication to diversity and advancement, resonating positively with investors and buoying the stock price.
  • In a quest for high-yield dividend opportunities to offset inflation, Medtronic's reliability and growth potential have piqued investors' interest, further fueling the bullish momentum in the stock.

17.06.2024 - MDT Stock was up 3.9%

  • Medtronic's bullish movement could be attributed to being a high-yield dividend stock beating inflation, attracting investors looking to counter the effects of rising prices.
  • The focus on undervalued healthcare stocks in the market could have positively impacted Medtronic's stock as investors seek opportunities in this sector.
  • The integration of AI in healthcare for better patient outcomes could also have contributed to the positive sentiment around healthcare stocks, including Medtronic.
  • The search for undervalued breakout stocks in the market may have led investors to discover the potential in companies like Medtronic, driving the bullish movement.

22.04.2025 - MDT Stock was down 5.8%

  • Despite delivering strong fourth-quarter fiscal 2025 results with improvements in margins, Medtronic's stock experienced a bearish movement.
  • The decision to spin off its Diabetes business into a standalone company could have initially raised concerns among investors about the potential impact on overall performance.
  • The beat in Q4 earnings and revenue estimates might not have been substantial enough to offset broader market sentiment or concerns about the upcoming restructuring.
  • Investor optimism about Medtronic's strength in the Cardiovascular portfolio may have been overshadowed by uncertainties surrounding the strategic shift in the company's business structure.

01.09.2025 - MDT Stock was down 2.3%

  • Medtronic's stock price saw a 1.5% decrease amidst overall market pessimism.
  • The larger decline in Medtronic's stock compared to the market suggests company-specific influences.
  • Potential factors contributing to the bearish trend may involve earnings discrepancies, regulatory hurdles, or adverse developments impacting investor trust in the company's outlook.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.